Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120030324 | 12003032 | 4 | F | 20160117 | 20160714 | 20160204 | 20160727 | EXP | US-PFIZER INC-2016066154 | PFIZER | 70.00 | YR | F | Y | 73.00000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120030324 | 12003032 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, CYCLIC (TWICE A DAY, 3 WEEKS AND STOP FOR 1 WEEK ) | Y | 258CA | 21938 | 37.5 | MG | CAPSULE, HARD | |||||
| 120030324 | 12003032 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, 1X/DAY | Y | 258CA | 21938 | 37.5 | MG | CAPSULE, HARD | QD | |||||
| 120030324 | 12003032 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, 1X/DAY | Y | X731C | 21938 | 37.5 | MG | CAPSULE, HARD | QD | |||||
| 120030324 | 12003032 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, 1X/DAY | Y | 258CA | 21938 | 37.5 | MG | CAPSULE, HARD | QD | |||||
| 120030324 | 12003032 | 5 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, UNK | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 120030324 | 12003032 | 6 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, 1X/DAY | Y | 21938 | 37.5 | MG | CAPSULE, HARD | QD | ||||||
| 120030324 | 12003032 | 7 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, UNK | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 120030324 | 12003032 | 8 | C | ANASTROZOLE. | ANASTROZOLE | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | ||||||
| 120030324 | 12003032 | 9 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | |||||||
| 120030324 | 12003032 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD | ||||||||
| 120030324 | 12003032 | 11 | C | CALCIUM + VIT D | CALCIUMVITAMIN D | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120030324 | 12003032 | 1 | Renal cancer metastatic |
| 120030324 | 12003032 | 8 | Hormone replacement therapy |
| 120030324 | 12003032 | 9 | Hypertension |
| 120030324 | 12003032 | 10 | Blood cholesterol |
| 120030324 | 12003032 | 11 | Vitamin supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120030324 | 12003032 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120030324 | 12003032 | Abdominal discomfort | |
| 120030324 | 12003032 | Abdominal pain upper | |
| 120030324 | 12003032 | Asthenia | |
| 120030324 | 12003032 | Decreased appetite | |
| 120030324 | 12003032 | Malaise | |
| 120030324 | 12003032 | Pain | |
| 120030324 | 12003032 | Peripheral swelling | |
| 120030324 | 12003032 | Platelet count decreased | |
| 120030324 | 12003032 | Somnolence | |
| 120030324 | 12003032 | Swelling | |
| 120030324 | 12003032 | Weight decreased | |
| 120030324 | 12003032 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120030324 | 12003032 | 1 | 20160129 | 0 | ||
| 120030324 | 12003032 | 2 | 20160223 | 0 | ||
| 120030324 | 12003032 | 3 | 20160322 | 0 | ||
| 120030324 | 12003032 | 4 | 20160419 | 0 | ||
| 120030324 | 12003032 | 8 | 2011 | 0 | ||
| 120030324 | 12003032 | 9 | 2011 | 0 | ||
| 120030324 | 12003032 | 10 | 2011 | 0 | ||
| 120030324 | 12003032 | 11 | 2011 | 0 |